Neuralink knew from animal testing it ran ahead of its US approval that tiny implanted wires might retract, removing sensitive electrodes that decode brain signals, sources say, and that Neuralink deemed the risk low enough for a redesign not to be merited
Source:
About Reuters
Top and breaking news, pictures and videos from Reuters. For more breaking business news, follow @ReutersBiz. Our new daily podcast is here: https://t.co/KO0QFy0d3a